Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis.

Wang Chung KwokTerence Chi Chun TamDavid Chi Leung LamMary Sau Man IpJames Chung Man Ho

Published in: The clinical respiratory journal (2023)

Baseline eosinophil count of 3.5% might serve as a marker to predict the benefits of ICS on exacerbation risk among patients with non-CF bronchiectasis.

Keyphrases

cystic fibrosis
chronic obstructive pulmonary disease
peripheral blood
intensive care unit
respiratory failure